Clinical Case Vignette — Anti-Amyloid Therapy ARIA-E After Donanemab in an APOE ε4 Carrier: Risk Stratification, Management, and Rechallenge Considerations…
Anti-Amyloid Therapy Candidacy in APOE ε4 Heterozygotes with Prior Microhemorrhages | ApoE4 Insights Clinical Content — For Licensed Healthcare Professionals…
A physician’s review of a popular sleep program, and what the evidence actually says about sleep and APOE ε4 risk.
APOE, APOE ε4, and ApoE4 refer to the gene, the allele, and the protein isoform respectively — distinctions routinely conflated in both clinical and lay writing. A short reference on correct usage and why the precision matters in practice and in the literature.
A board-certified neurologist and APOE ε4 carrier reviews Dale Bredesen’s bestselling protocol — what the evidence supports, and where it overclaims.
Evidence-Based Review APOE ε4 · Pre-Symptomatic 2026 · Peer-Reviewed Synthesis APOE ε4 Carrier: Pre-SymptomaticEvidence-Based Management What to do — and…
A critical appraisal of the SNAC-K cohort analysis (JAMA Network Open, 2026; n=2,157) reporting that higher meat intake was associated with slower cognitive decline in APOE ε4 carriers but not in non-carriers. Assessed against Bradford Hill criteria, with attention to processed versus unprocessed meat and the limits of observational nutrition evidence.
Timing matters more than dose. Omega-3 DHA appears most useful for APOE ε4 carriers who start well before any memory symptoms — the largest trial in people who already had Alzheimer’s dementia found no cognitive benefit in ε4 carriers. The form matters too: fatty fish and roe deliver DHA by a route into the brain that ordinary fish oil capsules largely miss.
DHA supplementation in APOE ε4 carriers is stage-dependent. High-dose DHA (≥1–2 g/day) initiated before cognitive decline carries the strongest rationale, while the ADCS trial (Quinn et al., JAMA 2010; n=402) found no benefit in ε4 carriers with established dementia. Molecular form matters: phospholipid-DHA reaches the brain via MFSD2A transport, a route standard triglyceride fish oil does not use.
Distinguishing iNPH from Alzheimer Disease: Key Imaging Differences Neuroimaging · Clinical Differentiation · 2025 Distinguishing iNPH from Alzheimer Disease: Key…